Associations between DNA methylation and schizophrenia-related intermediate phenotypes - A gene set enrichment analysis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 59, Issue , 2015, Pages 31-39

  Hass, Johanna ^a   Walton, Esther ^a   Wright, Carrie ^b,e   Beyer, Andreas ^a,c   Scholz, Markus ^d   Turner, Jessica ^e,f   Liu, Jingyu ^e,j   Smolka, Michael N ^a   Roessner, Veit ^a   Sponheim, Scott R ^g   Gollub, Randy L ^h,i   Calhoun, Vince D ^e,j   Ehrlich, Stefan ^a,h,i  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e MIND RESEARCH NETWORK   (United States)

^f UNIVERSITY OF NEW MEXICO   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j MSC01 1070   (United States)

more..

Author keywords

DNA methylation; GSEA; Intermediate phenotype; MicroRNA targets; Schizophrenia

Indexed keywords

MICRORNA; MICRORNA 219A 5P; UNCLASSIFIED DRUG; OXYGEN;

ADULT; ARTICLE; BEHAVIOR DISORDER; BRAIN FUNCTION; BRAIN SIZE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DNA METHYLATION; EPHA4 GENE; EPIGENETICS; ESR1 GENE; FEMALE; GENE; GENE SET ENRICHMENT ANALYSIS; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PKNOX1 GENE; SCHIZOPHRENIA; BLOOD; CLINICAL TRIAL; FACTUAL DATABASE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDY; GENETIC EPIGENESIS; GENETICS; IMAGE PROCESSING; MENTAL HEALTH; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; RECOGNITION; STATISTICS AND NUMERICAL DATA; VASCULARIZATION; YOUNG ADULT;

ADULT; DATABASES, FACTUAL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MICRORNAS; MIDDLE AGED; OXYGEN; PHENOTYPE; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84921731271     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2015.01.006     Document Type: Article

References (126)

1. Amin Z., Canli T., Epperson C.N. Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev 2005, 4:43-58.
2. Antonova E., Sharma T., Morris R., Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 2004, 70:117-145.
3. Axmacher N., Haupt S., Cohen M.X., Elger C.E., Fell J. Interference of working memory load with long-term memory formation. Eur J Neurosci 2009, 29:1501-1513.
4. Barry W.T., Nobel A.B., Wright F.A. Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 2005, 21:1943-1949.
5. Barta P.E., Pearlson G.D., Powers R.E., Richards S.S., Tune L.E. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990, 147:1457-1462.
6. Berman K.F., Schmidt P.J., Rubinow D.R., Danaceau M.A., Van Horn J.D., Esposito G., et al. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A 1997, 94:8836-8841.
7. Beveridge N.J., Gardiner E., Carroll A.P., Tooney P.A., Cairns M.J. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010, 15:1176-1189.
8. Boks M.P., Derks E.M., Weisenberger D.J., Strengman E., Janson E., Sommer I.E., et al. The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 2009, 4:e6767.
9. Bosia M., Riccaboni R., Poletti S. Neurofunctional correlates of theory of mind deficits in schizophrenia. Curr Top Med Chem 2012, 12:2284-2302.
10. Bowie C.R., Harvey P.D. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat 2006, 2:531-536.
11. Brauns S., Gollub R.L., Roffman J.L., Yendiki A., Ho B.-C., Wassink T.H., et al. DISC1 is associated with cortical thickness and neural efficiency. Neuroimage 2011, 57:1591-1600.
12. Camchong J., Lim K.O., Sponheim S.R., Macdonald A.W. Frontal white matter integrity as an endophenotype for schizophrenia: diffusion tensor imaging in monozygotic twins and patients' nonpsychotic relatives. Front Hum Neurosci 2009, 3:35.
13. Chen Y.-H., Edgar J.C., Huang M., Hunter M.A., Epstein E., Howell B., et al. Frontal and superior temporal auditory processing abnormalities in schizophrenia. Neuroimage Clin 2013, 2:695-702.
14. Cheng H.-Y.M., Papp J.W., Varlamova O., Dziema H., Russell B., Curfman J.P., et al. microRNA modulation of circadian-clock period and entrainment. Neuron 2007, 54:813-829.
15. Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee S.H., Ripke S., Neale B.M., Faraone S.V., Purcell S.M., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013, 45:984-994.
16. Curradi M., Izzo A., Badaracco G., Landsberger N. Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol 2002, 22:3157-3173.
17. Edgar J.C., Chen Y.H., Lanza M., Howell B., Chow V.Y., Heiken K., et al. Cortical thickness as a contributor to abnormal oscillations in schizophrenia?. Neuroimage Clin 2013, 4:122-129.
18. Efron B., Tibshirani R. On testing the significance of sets of genes. Ann Appl Stat 2007, 1:107-129.
19. Egea J., Klein R. Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol 2007, 17:230-238.
20. Ehrlich S., Morrow E.M., Roffman J.L., Wallace S.R., Naylor M., Bockholt H.J., et al. The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults. Neuroimage 2010, 53:992-1000.
21. Ehrlich S., Brauns S., Yendiki A., Ho B.-C., Calhoun V., Schulz S.C., et al. Associations of cortical thickness and cognition in patients with schizophrenia and healthy controls. Schizophr Bull 2011, 38:1050-1062.
22. Ehrlich S., Geisler D., Yendiki A., Panneck P., Roessner V., Calhoun V.D., et al. Associations of white matter integrity and cortical thickness in patients with schizophrenia and healthy controls. Schizophr Bull 2014, 40:665-674.
23. Filosa A., Paixão S., Honsek S.D., Carmona M.A., Becker L., Feddersen B., et al. Neuron-glia communication via EphA4/ephrin-A3 modulates LTP through glial glutamate transport. Nat Neurosci 2009, 12:1285-1292.
24. First M., Spitzer A., Gibbon M., Williams J. Structured clinical interview for DSM-IV-TR axis I disorders, research version 2002, New York State Psychiatric Institute, New York. Nonpatient ed.
25. Flaum M., O'Leary D.S., Swayze V.W., Miller D.D., Arndt S., Andreasen N.C. Symptom dimensions and brain morphology in schizophrenia and related psychotic disorders. J Psychiatr Res 1995, 29:261-276.
26. Galimberti I., Bednarek E., Donato F., Caroni P. EphA4 signaling in juveniles establishes topographic specificity of structural plasticity in the hippocampus. Neuron 2010, 65:627-642.
27. Gasbarri A., Tavares M.C.H., Rodrigues R.C., Tomaz C., Pompili A. Estrogen, cognitive functions and emotion: an overview on humans, non-human primates and rodents in reproductive years. Rev Neurosci 2012, 23:587-606.
28. Geeleher P., Hartnett L., Egan L.J., Golden A., Raja Ali R.A., Seoighe C. Gene-set analysis is severely biased when applied to genome-wide methylation data. Bioinformatics 2013, 29:1851-1857.
29. Gollub R.L., Shoemaker J.M., King M.D., White T., Ehrlich S., Sponheim S.R., et al. The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. Neuroinformatics 2013, 11:367-388.
30. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645.
31. Gräff J., Kim D., Dobbin M.M., Tsai L.-H. Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol Rev 2011, 91:603-649.
32. Grayson D.R., Guidotti A. The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology 2013, 38:138-166.
33. Gregório S.P., Sallet P.C., Do K.-A., Lin E., Gattaz W.F., Dias-Neto E. Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: preliminary evidence. Psychiatry Res 2009, 165:1-9.
34. Grunau C., Hindermann W., Rosenthal A. Large-scale methylation analysis of human genomic DNA reveals tissue-specific differences between the methylation profiles of genes and pseudogenes. Hum Mol Genet 2000, 9:2651-2663.
35. Hansen T., Olsen L., Lindow M., Jakobsen K.D., Ullum H., Jonsson E., et al. Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One 2007, 2:e873.
36. Harris L.W., Lockstone H.E., Khaitovich P., Weickert C.S., Webster M.J., Bahn S. Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia. BMC Med Genomics 2009, 2:28.
37. Hass J., Walton E., Kirsten H., Liu J., Priebe L., Wolf C., et al. A genome-wide association study suggests novel loci associated with a schizophrenia-related brain-based phenotype. PLoS One 2013, 8:e64872.
38. Hawrylycz M.J., Lein E.S., Guillozet-Bongaarts A.L., Shen E.H., Ng L., Miller J.A., et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012, 489:391-399.
39. Herzog E., Galvez J., Roks A., Stolk L., Verbiest M., Eilers P., et al. Tissue-specific DNA methylation profiles in newborns. Clin Epigenetics 2013, 5:8.
40. Honea R., Crow T.J., Passingham D., Mackay C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005, 162:2233-2245.
41. Huang C., Cai Z., Huang M., Mao C., Zhang Q., Lin Y., et al. MiR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α. J Clin Endocrinol Metab 2014, [jc20142883].
42. Kantrowitz J., Javitt D.C. Glutamatergic transmission in schizophrenia: from basic research to clinical practice. Curr Opin Psychiatry 2012, 25:96-102.
43. Karatsoreos I.N. Links between circadian rhythms and psychiatric disease. Front Behav Neurosci 2014, 8:162.
44. Karlsgodt K.H., Sanz J., van Erp T.G., Bearden C.E., Nuechterlein K.H., Cannon T.D. Re-evaluating dorsolateral prefrontal cortex activation during working memory in schizophrenia. Schizophr Res 2009, 108:143-150.
45. Kasai K., Shenton M.E., Salisbury D.F., Hirayasu Y., Lee C.U., Ciszewski A.A., et al. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry 2003, 160:156-164.
46. Keefe R.S.E., Harvey P.D. Cognitive impairment in schizophrenia. Handb Exp Pharmacol 2012, 11-37.
47. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., et al. The human genome browser at UCSC. Genome Res 2002, 12:996-1006.
48. Kim D.I., Sui J., Rachakonda S., White T., Manoach D.S., Clark V.P., et al. Identification of imaging biomarkers in schizophrenia: a coefficient-constrained independent component analysis of the mind multi-site schizophrenia study. Neuroinformatics 2009, 8:213-229.
49. Knickmeyer R.C., Wang J., Zhu H., Geng X., Woolson S., Hamer R.M., et al. Common variants in psychiatric risk genes predict brain structure at birth. Cereb Cortex 2014, 24:1230-1246.
50. Kocerha J., Faghihi M.A., Lopez-Toledano M.A., Huang J., Ramsey A.J., Caron M.G., et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A 2009, 106:3507-3512.
51. Kos M., Denger S., Reid G., Gannon F. Upstream open reading frames regulate the translation of the multiple mRNA variants of the estrogen receptor alpha. J Biol Chem 2002, 277:37131-37138.
52. Kulkarni J., Gavrilidis E., Worsley R., Hayes E. Role of estrogen treatment in the management of schizophrenia. CNS Drugs 2012, 26:549-557.
53. Kwon E., Wang W., Tsai L.-H. Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol Psychiatry 2013, 18:11-12.
54. Lai Y., Zhang F., Nayak T.K., Modarres R., Lee N.H., McCaffrey T.A. Concordant integrative gene set enrichment analysis of multiple large-scale two-sample expression data sets. BMC Genomics 2014, 15(Suppl. 1):S6.
55. Li Z.-H., Xu H., Zheng W., Lam S.H., Gong Z. RNA-sequencing analysis of TCDD-induced responses in zebrafish liver reveals high relatedness to in vivo mammalian models and conserved biological pathways. PLoS One 2013, 8:e77292.
56. Li J.-H., Liu S., Zhou H., Qu L.-H., Yang J.-H. StarBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 2014, 42(Database issue):D92-D97.
57. Liu J., Morgan M., Hutchison K., Calhoun V.D. A study of the influence of sex on genome wide methylation. PLoS One 2010, 5:e10028.
58. Liu J., Hutchison K., Perrone-Bizzozero N., Morgan M., Sui J., Calhoun V. Identification of genetic and epigenetic marks involved in population structure. PLoS One 2010, 5:e13209.
59. Liu X., Lai Y., Wang X., Hao C., Chen L., Zhou Z., et al. Reduced white matter integrity and cognitive deficit in never-medicated chronic schizophrenia: a diffusion tensor study using TBSS. Behav Brain Res 2013, 252:157-163.
60. Liu J., Chen J., Ehrlich S., Walton E., White T., Perrone-Bizzozero N., et al. Methylation patterns in whole blood correlate with symptoms in schizophrenia patients. Schizophr Bull 2014, 40:769-776.
61. Liu B., Zhang X., Hou B., Li J., Qiu C., Qin W., et al. The impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjects. Neuropsychopharmacology 2014, 39:2153-2160.
62. Lonard D.M., Nawaz Z., Smith C.L., O'Malley B.W. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell 2000, 5:939-948.
63. Long F., Liu H., Hahn C., Sumazin P., Zhang M.Q., Zilberstein A. Genome-wide prediction and analysis of function-specific transcription factor binding sites. In Silico Biol 2004, 4:395-410.
64. Manoach D.S. Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr Res 2003, 60:285-298.
65. Manoach D.S., Press D.Z., Thangaraj V., Searl M.M., Goff D.C., Halpern E., et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 1999, 45:1128-1137.
66. Martorell L., Costas J., Valero J., Gutierrez-Zotes A., Phillips C., Torres M., et al. Analyses of variants located in estrogen metabolism genes (ESR1, ESR2, COMT and APOE) and schizophrenia. Schizophr Res 2008, 100:308-315.
67. Melas P.A., Rogdaki M., Ösby U., Schalling M., Lavebratt C., Ekström T.J. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J 2012, 26:2712-2718.
68. Meltzer H.Y., Rajagopal L., Huang M., Oyamada Y., Kwon S., Horiguchi M. Translating the N-methyl-d-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia. Int J Neuropsychopharmacol 2013, 16:2181-2194.
69. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 2006, 7:818-827.
70. Miyata J., Sasamoto A., Koelkebeck K., Hirao K., Ueda K., Kawada R., et al. Abnormal asymmetry of white matter integrity in schizophrenia revealed by voxelwise diffusion tensor imaging. Hum Brain Mapp 2012, 33:1741-1749.
71. Mori T., Ohnishi T., Hashimoto R., Nemoto K., Moriguchi Y., Noguchi H., et al. Progressive changes of white matter integrity in schizophrenia revealed by diffusion tensor imaging. Psychiatry Res 2007, 154:133-145.
72. Muñoz Maniega S., Lymer G.K.S., Bastin M.E., Marjoram D., Job D.E., Moorhead T.W.J., et al. A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia. Schizophr Res 2008, 106:132-139.
73. Nenadic I., Smesny S., Schlösser R.G.M., Sauer H., Gaser C. Auditory hallucinations and brain structure in schizophrenia: voxel-based morphometric study. Br J Psychiatry 2010, 196:412-413.
74. Nishioka M., Bundo M., Kasai K., Iwamoto K. DNA methylation in schizophrenia: progress and challenges of epigenetic studies. Genome Med 2012, 4:96.
75. O'Donovan M.C., Craddock N.J., Owen M.J. Genetics of psychosis; insights from views across the genome. Hum Genet 2009, 126:3-12.
76. Patterson N., Price A.L., Reich D. Population structure and eigenanalysis. PLoS Genet 2006, 2:e190.
77. Pereira P.L., Magnol L., Sahún I., Brault V., Duchon A., Prandini P., et al. A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. Hum Mol Genet 2009, 18:4756-4769.
78. Perlman W.R., Webster M.J., Kleinman J.E., Weickert C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol Psychiatry 2004, 56:844-852.
79. Perlman W.R., Tomaskovic-Crook E., Montague D.M., Webster M.J., Rubinow D.R., Kleinman J.E., et al. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness. Biol Psychiatry 2005, 58:812-824.
80. Pidsley R., Wong CC Y., Volta M., Lunnon K., Mill J., Schalkwyk L.C. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics 2013, 14:293.
81. Popov N.T., Stoyanova V.K., Madzhirova N.P., Vachev T.I. Epigenetic aspects in schizophrenia etiology and pathogenesis. Folia Med (Plovdiv) 2012, 54:12-16.
82. Potkin S.G., Turner J.A., Brown G.G., McCarthy G., Greve D.N., Glover G.H., et al. FBIRN: working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophr Bull 2009, 35:19-31.
83. Potkin S.G., Turner J.A., Guffanti G., Lakatos A., Fallon J.H., Nguyen D.D., et al. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull 2009, 35:96-108.
84. Potkin S.G., Macciardi F., Guffanti G., Fallon J.H., Wang Q., Turner J.A., et al. Identifying gene regulatory networks in schizophrenia. Neuroimage 2010, 53:839-847.
85. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909.
86. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kähler A.K., Akterin S., et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013, 45:1150-1159.
87. Roffman J.L., Gollub R.L., Calhoun V.D., Wassink T.H., Weiss A.P., Ho B.C., et al. MTHFR 677C→T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val→Met. Proc Natl Acad Sci U S A 2008, 105:17573-17578.
88. Roig B., Virgos C., Franco N., Martorell L., Valero J., Costas J., et al. The discoidin domain receptor 1 as a novel susceptibility gene for schizophrenia. Mol Psychiatry 2007, 12:833-841.
89. Roth T.L., Lubin F.D., Sodhi M., Kleinman J.E. Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta 2009, 1790:869-877.
90. Sato F., Tsuchiya S., Meltzer S.J., Shimizu K. MicroRNAs and epigenetics. FEBS J 2011, 278:1598-1609.
91. Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014, 511:421-427.
92. Schmitt A., Leonardi-Essmann F., Durrenberger P.F., Parlapani E., Schneider-Axmann T., Spanagel R., et al. Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study. World J Biol Psychiatry 2011, 12:201-215.
93. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
94. Shin C., Nam J.-W., Farh K.K.-H., Chiang H.R., Shkumatava A., Bartel D.P. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010, 38:789-802.
95. Smalheiser N.R., Lugli G., Zhang H., Rizavi H., Cook E.H., Dwivedi Y. Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One 2014, 9.
96. Stein J.L., Medland S.E., Vasquez A.A., Hibar D.P., Senstad R.E., Winkler A.M., et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 2012, 44:552-561.
97. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005, 102:15545-15550.
98. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003, 60:1187-1192.
99. Taguchi Y.-H. MicroRNA-mediated regulation of target genes in several brain regions is correlated to both microRNA-targeting-specific promoter methylation and differential microRNA expression. BioData Min 2013, 6:11.
100. Takeyama J., Suzuki T., Inoue S., Kaneko C., Nagura H., Harada N., et al. Expression and cellular localization of estrogen receptors alpha and beta in the human fetus. J Clin Endocrinol Metab 2001, 86:2258-2262.
101. Tremblay M.-E., Riad M., Chierzi S., Murai K.K., Pasquale E.B., Doucet G. Developmental course of EphA4 cellular and subcellular localization in the postnatal rat hippocampus. J Comp Neurol 2009, 512:798-813.
102. Vahey M.T., Wang Z., Kester K.E., Cummings J., Heppner D.G., Nau M.E., et al. Expression of genes associated with immunoproteasome processing of major histocompatibility complex peptides is indicative of protection with adjuvanted RTS, S malaria vaccine. J Infect Dis 2010, 201:580-589.
103. Van Erp T.G.M., Saleh P.A., Huttunen M., Lönnqvist J., Kaprio J., Salonen O., et al. Hippocampal volumes in schizophrenic twins. Arch Gen Psychiatry 2004, 61:346-353.
104. Van Erp T.G., Guella I., Vawter M.P., Turner J., Brown G.G., McCarthy G., et al. Schizophrenia miR-137 locus risk genotype is associated with dorsolateral prefrontal cortex hyperactivation. Biol Psychiatry 2014, 75:398-405.
105. Velakoulis D., Wood S.J., Wong M.T.H., McGorry P.D., Yung A., Phillips L., et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 2006, 63:139-149.
106. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
107. Walton E., Geisler D., Lee P.H., Hass J., Turner J.A., Liu J., et al. Prefrontal inefficiency is associated with polygenic risk for schizophrenia. Schizophr Bull 2013, sbt174.
108. Walton E., Turner J., Gollub R.L., Manoach D.S., Yendiki A., Ho B.-C., et al. Cumulative genetic risk and prefrontal activity in patients with schizophrenia. Schizophr Bull 2013, 39:703-711.
109. Wang W., Kwon E.J., Tsai L.-H. MicroRNAs in learning, memory, and neurological diseases. Learn Mem 2012, 19:359-368.
110. Wechsler D. Wechsler Memory Scale 1997, Psychological Corporation, San Antonio, TX. 3rd ed.
111. Wechsler D. Wechsler Adult Intelligence Scale 1997, Psychological Corporation, San Antonio, TX. 3rd ed.
112. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., et al. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008, 17:2293-2309.
113. Whitwell J.L., Crum W.R., Watt H.C., Fox N.C. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 2001, 22:1483-1489.
114. Woolrich M.W., Ripley B.D., Brady M., Smith S.M. Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 2001, 14:1370-1386.
115. Wright C., Turner J.A., Calhoun V.D., Perrone-Bizzozero N. Potential impact of miR-137 and its targets in schizophrenia. Front Genet 2013, 4:58.
116. Wu J.Q., Ruth Sassé T., Wolkenstein G., Conceicao V., Miranda Saksena M., Soedjono M., et al. Transcriptome analysis of primary monocytes shows global down-regulation of genetic networks in HIV viremic patients versus long-term non-progressors. Virology 2013, 435:308-319.
117. Wu Y.C., Hill R.A., Gogos A., van den Buuse M. Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF. Neuroscience 2013, 239:67-83.
118. Xiong Q., Ancona N., Hauser E.R., Mukherjee S., Furey T.S. Integrating genetic and gene expression evidence into genome-wide association analysis of gene sets. Genome Res 2012, 22:386-397.
119. Xu N.-J., Henkemeyer M. Ephrin reverse signaling in axon guidance and synaptogenesis. Semin Cell Dev Biol 2012, 23:58-64.
120. Yang J.-H., Li J.-H., Shao P., Zhou H., Chen Y.-Q., Qu L.-H. StarBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 2011, 39(Database issue):D202-D209.
121. Yendiki A., Greve D.N., Wallace S., Vangel M., Bockholt J., Mueller B.A., et al. Multi-site characterization of an fMRI working memory paradigm: reliability of activation indices. Neuroimage 2010, 53:119-131.
122. Yoshida T., McCarley R.W., Nakamura M., Lee K., Koo M.-S., Bouix S., et al. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res 2009, 113:84-94.
123. Yu C.-C., Furukawa M., Kobayashi K., Shikishima C., Cha P.-C., Sese J., et al. Genome-wide DNA methylation and gene expression analyses of monozygotic twins discordant for intelligence levels. PLoS One 2012, 7:e47081.
124. Zhang F.F., Cardarelli R., Carroll J., Fulda K.G., Kaur M., Gonzalez K., et al. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics 2011, 6:623-629.
125. Zhang B., Zhou Y., Lin N., Lowdon R.F., Hong C., Nagarajan R.P., et al. Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm. Genome Res 2013, 23:1522-1540.
126. Zhao X., He X., Han X., Yu Y., Ye F., Chen Y., et al. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 2010, 65:612-626.